Abstract PO1-20-04: STX-478-101: A phase 1/2, first-in-human study of STX-478 monotherapy or in combination with fulvestrant in patients with breast cancer or other advanced solid tumors (trial in progress)
Montero, Alberto, Orr, Douglas, Munster, Pamela, LoRusso, Patricia, Jhaveri, Komal, Pluard, Timothy, Winer, Ira, Streit, Michael, Patterson, Monica, Roberts, Simon, Corsi-Travali, Stefani, Ewert, Courtney, Juric, Dejan
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article